Immunohistochemical localization of CB1 cannabinoid receptors in frontal cortex and related limbic areas in obese Zucker rats: Effects of chronic fluoxetine treatment

Brain Research

Volumn 1236, Issue , 2008, Pages 57-72

  Zarate, J ^a   Churruca, I ^a   Echevarria E ^a   Casis, L ^a   Lopez de Jesus M ^a   Saenz del Burgo, L ^a   Salles J ^a  

^a UNIVERSITY OF THE BASQUE COUNTRY UPV EHU   (Spain)

Author keywords

CB1 cannabinoid receptors; Chronic antidepressant treatment; Fluoxetine; Frontal cortex; Obese Zucker rat; Phosphorylated and nonphosphorylated CB1 receptors

Indexed keywords

CANNABINOID 1 RECEPTOR; ENDOCANNABINOID; FLUOXETINE; POLYCLONAL ANTIBODY; SEROTONIN UPTAKE INHIBITOR;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BRAIN NERVE CELL; CELL DENSITY; CHRONIC DRUG ADMINISTRATION; CINGULATE GYRUS; CONTROLLED STUDY; DRUG EFFECT; FOREBRAIN; FRONTAL CORTEX; IMMUNOHISTOCHEMISTRY; LIMBIC CORTEX; MALE; NONHUMAN; OBESITY; OCCIPITAL CORTEX; PARIETAL LOBE; PRIORITY JOURNAL; PROTEIN DOMAIN; PROTEIN EXPRESSION; PROTEIN FUNCTION; PROTEIN LOCALIZATION; PROTEIN PHOSPHORYLATION; PYRIFORM CORTEX; RAT; RECEPTOR DENSITY; TEMPORAL CORTEX; TISSUE DISTRIBUTION; WESTERN BLOTTING; ZUCKER RAT; ANALYSIS OF VARIANCE; ANIMAL; CELL COUNT; DISEASE MODEL; DOSE RESPONSE; FRONTAL LOBE; GENE EXPRESSION REGULATION; GENETICS; LIMBIC SYSTEM; METABOLISM; PATHOLOGY;

ANIMALIA; RATTUS;

ANALYSIS OF VARIANCE; ANIMALS; CELL COUNT; DISEASE MODELS, ANIMAL; DOSE-RESPONSE RELATIONSHIP, DRUG; FLUOXETINE; FRONTAL LOBE; GENE EXPRESSION REGULATION; LIMBIC SYSTEM; MALE; OBESITY; RATS; RATS, ZUCKER; RECEPTOR, CANNABINOID, CB1; SEROTONIN UPTAKE INHIBITORS;

EID: 53049104674     PISSN: 00068993     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.brainres.2008.07.100     Document Type: Article

References (123)

1. Ahima R.S. Leptin and the neuroendocrinology of fasting. Front. Horm. Res. 26 (2000) 42-56
2. Ahissar E., and Arieli A. Figuring space by time. Neuron 32 (2001) 185-201
3. Alger B.E. Retrograde signalling in the regulation of synaptic transmission: focus on endocannabinoids. Prog. Neurobiol. 68 (2002) 247-286
4. Amat J., Baratta M.V., Paul E., Bland S.T., Watkins L.R., and Maier S.F. Medial prefrontal cortex determines how stressor controllability affects behaviour and dorsal raphe nucleus. Nat. Neurosci. 8 (2005) 365-371
5. Amat J., Paul E., Zarza C., Watkins L.R., and Maier S.F. Previous experience with behavioural control over stress blocks the behavioural and dorsal raphe nucleus activating effects of later uncontrollable stress: role of ventral medial prefrontal cortex. J. Neurosci. 26 (2006) 13264-13272
6. Auclair N., Otani S., Soubrie P., and Crepel F. Cannabinoids modulate synaptic strength and plasticity at glutamatergic synapses of rat prefrontal cortex pyramidal neurons. J. Neurophysiol. 83 (2000) 3287-3293
7. Bacci A., Huguenard J.R., and Prince D.A. Long-lasting self-inhibition of neocortical interneurons mediated by endocannabinoids. Nature 431 (2004) 312-316
8. Bambico F.R., Katz N., Debonnel G., and Gobbi G. Cannabinoids elicit antidepressant-like behavior and activate serotonergic neurons through the medial prefrontal cortex. J. Neurosci. 27 (2007) 11700-11711
9. Bjartmar L., Johansson I.M., Marcusson J., Ross S.B., Seckl J.R., and Olsson T. Selective effects on NGFI-A, MR, GR, and NGFI-B hippocampal mRNA expression after chronic treatment with different subclasses of antidepressants in the rat. Psychopharmacol. (Berl) 151 (2000) 7-12
10. Bodor A.L., Katona I., Nyiri G., Mackie K., Ledent C., Hajos N., and Freund T.F. Endocannabinoid signalling in rat somatosensory cortex: laminar differences and involvement of specific interneuron types. J. Neurosci. 25 (2005) 6845-6856
11. Brady L.S., Gold P.W., Herkenham M., Lynn A.B., and Whitfield Jr. H.J. The antidepressants fluoxetine, idazoxan and phenelzine alter corticotrophin-releasing hormone and tyrosine hydroxylase mRNA levels in rat brain: therapeutic implications. Brain Res. 14 (1992) 117-135
12. Buckingham J.C. Glucocorticoids: exemplars of multi-tasking. Br. J. Pharmacol. 147 (2006) S258-S268
13. Calapai G., Corica F., Corsonello A., Sautebin L., Di Rosa M., Campo G.M., Buemi M., Mauro V.N., and Caputi A.P. Leptin increases serotonin turnover by inhibition of brain nitric oxide synthesis. J. Clin. Invest. 104 (1999) 975-982
14. Carr D.B., and Sesack S.R. Projections from the rat prefrontal cortex to the ventral tegmental area: target specificity in the synaptic associations with mesoaccumbens and mesocortical neurons. J. Neurosci. 20 (2000) 3864-3873
15. Celada P., Puig M.V., Casanovas J.M., Guillazo G., and Artigas F. Control of dorsal raphe serotonergic neurons by the medial prefrontal córtex: involvement of serotonin-1A, GABA(A) and glutamate receptors. J. Neurosci. 21 (2001) 9917-9929
16. Charnay Y., Cusin I., Vallet P.G., Muzzin P., Rohner-Jeanrenaud F., and Bouras C. Intracerebroventricular infusion of leptin decreases serotonin transporter binding sites in the frontal cortex of the rat. Neurosci. Lett. 283 (2000) 89-92
17. Christensen R., Kristensen P.K., Bartels E.M., Bliddal H., and Astrup A. Efficacy and safety of the weight-loss drug rimonabant: a meta-analysis of randomised trials. Lancet 270 (2007) 1706-1713
18. Coutts A.A., Anavi-Goffer S., Ross R.A., MacEwan D.J., Mackie K., Pertwee R.G., and Irving A.G. Agonist-induced internalization and trafficking of cannabinoid CB1 receptors in hippocampal neurons. J. Neurosci. 21 (2001) 2425-2433
19. Currie P.J. Differential effects of NE, CLON, and 5-HT on feeding and macronutrient selection in genetically obese (ob/ob) and lean mice. Brain Res. Bull. 32 (1993) 133-142
20. De Fanti B.A., Gavel D.A., Hamilton J.S., and Horwitz B.A. Extracellular hypothalamic serotonin levels after dorsal raphe nuclei stimulation of lean and obese Zucker rats. Brain Res. 869 (2000) 6-14
21. De Felipe J., and Jones E.G. A light and electron microscopic study of serotonin-immunoreactive fibers and terminals in the monkey sensory-motor cortex. Exp. Brain Res. 71 (1988) 171-182
22. De Felipe J., Hendry S.H., Hashikawa T., and Jones E.G. Synaptic relationships of serotonin-immunoreactive terminal baskets on GABA neurons in the cat auditory cortex. Cereb. Cortex 1 (1991) 117-133
23. Di S., Malcher-Lopes R., Halmos K.C., and Tasker J.G. Nongenomic glucocorticoid inhibition via endocannabinoid release in the hypothalamus: a fast feedback mechanism. J. Neurosci. 23 (2003) 4850-4857
24. Diana M.A., and Marty A. Endocannabinoid-mediated short-term synaptic plasticity: depolarization-induced suppression of inhibition (DSI) and depolarization-induced suppression of excitation (DSE). Br. J. Pharmacol. 142 (2004) 9-19
25. Di Marzo V., Goparaju S.K., Wang L., Liu J., Batkai S., Jarai Z., Fezza F., Miura G.I., Palmiter R.D., Sugiura T., and Kunos G. Leptin-regulated endocannabinoids are involved in maintaining food intake. Nature 410 (2001) 822-825
26. Diorio D., Viau V., and Meaney M.J. The role of the medial prefrontal cortex (cingulated gyrus) in the regulation of hypothalamic-pituitary-adrenal responses to stress. J. Neurosci. 13 (1993) 3839-3847
27. Domenici M.R., Azad S.C., Marsicano G., Schierloh A., Wotjak C.T., Dodt H.U., Zieglgänsberger W., Lutz B., and Rammes G. Cannabinoid receptor type 1 located on presynaptic terminals of principal neurons in the forebrain controls glutamatergic synaptic transmission. J. Neurosci. 26 (2006) 5794-5799
28. Dryden S., Brown M., King P., and Williams G. Decreased plasma leptin levels in lean and obese Zucker rats after treatment with the serotonin reuptake inhibitor fluoxetine. Horm. Metab. Res. 31 (1999) 363-366
29. Dwivedi Y., and Pandey G.N. Administration of dexametasone up-regulates protein kinase C activity and the expression of gamma and epsilon protein kinase C isoenzymes in rat brain. J. Neurochem. 72 (1999) 380-387
30. Egerton A., Allison C., Brett R.R., and Pratt J.A. Cannabinoids and prefrontal cortical function: Insights from clinical studies. Neurosci. Biobehav. Rev. 30 (2006) 680-695
31. Egertova M., and Elphick M.R. Localisation of cannabinoid receptors in the rat brain using antibodies to the intracellular C-terminal tail of CB1. J. Comp. Neurol. 422 (2000) 159-171
32. Fadda P., Scherma M., Salis P., Mascia P., Fattore L., and Fratta W. Involvement of the 5-HT1A serotonergic receptors in the anxiety-like effects induced by the CB1 receptor agonist WIN55,212-2. International Cannabinoid Research Society, 16 th Annual Symposium on the Cannabinoids, Tihany, Hungary, June 24-28 (2006)
33. Fortin D.A., and Levine E.S. Differential effects of endocannabinoids on glutamatergic and GABAergic inputs to layer 5 pyramidal neurons. Cereb. Cortex 17 (2007) 163-174
34. Fortin D.A., Trettel J., and Levine E.S. Brief trains of action potentials enhance pyramidal neuron excitability via endocannabinoid-mediated suppression of inhibition. J. Neurophysiol. 92 (2004) 2105-2112
35. Freedman M.R., Castonguay T.W., and Stern J.S. Effect of adrenalectomy and corticosterone replacement on meal patterns of Zucker rats. Am. J. Physiol. 249 (1985) R584-R594
36. Freund T.F., Katona I., and Piomelli D. Role of endogenous cannabinoids in synaptic signalling. Physiol. Rev. 83 (2003) 1017-1066
37. Friedman J.M., and Halaas J.L. Leptin and the regulation of body weight in mammals. Nature 395 (1998) 763-770
38. Gabbott P.L., Warner T.A., Jays P.R., Salway P., and Busby S.J. Prefrontal cortex in the rat: projections to subcortical autonomic, motor, and limbic centers. J. Comp. Neurol. 492 (2005) 145-177
39. Gandarias J.M., Echevarría E., Acebes I., Abecia L.C., Casis O., and Casis L. Effects of fluoxetine administration on mu-opioid receptor immunostaining in the rat forebrain. Brain Res. 817 (1999) 236-240
40. Garcia D.E., Brown S., Hille B., and Mackie K. Protein kinase C disrupts cannabinoid actions by phosphorylation of the CB1 cannabinoid receptor. J. Neurosci. 18 (1998) 2834-2841
41. Gobbi G., Bambico F.R., Mangieri R., Bortolato M., Campolongo P., Solinas M., Cassano T., Morgese M.G., Debonnel G., Duranti A., Tontini A., Tarzia G., Mor M., Trezza V., Goldberg S.R., and Coumo V. Antidepressant-like activity and modulation of brain monoaminergic transmission by blockade of anandamide hydrolysis. Proc. Natl. Acad. Sci. U. S. A. 102 (2005) 18620-18625
42. Gómez R., Navarro M., Ferrer B., Trigo J.M., Bilbao A., Del Arco I., Cippitelli A., Nava F., Piomelli D., and Rodríguez de Fonseca F. A peripheral mechanism for CB1 cannabinoid receptor-dependent modulation of feeding. J. Neurosci. 22 (2002) 9612-9617
43. Griebel G., Stemmelin J., and Scatton B. Effects of the cannabinoid CB1 receptor antagonist rimonabant in models of emotional reactivity in rodents. Biol. Psych. 57 (2005) 261-267
44. Groenewegen H.J., and Uylings H.B. The prefrontal cortex and the integration of sensory limbic and autonomic information. Prog. Brain Res. 126 (2000) 3-28
45. Guillaume-Gentil C., Rohner-Jeanrenaud F., Abramo F., Bestetti G.E., Rossi G.L., and Jeanrenaud B. Abnormal regulation of the hypothalamo-pituitary-adrenal axis in the genetically obese fa/fa rat. Endocrinol. 126 (1990) 1873-1879
46. Gutiérrez A., Saracíbar G., Casis L., Echevarría E., Rodríguez V.M., Macarulla M.T., Abecia L.C., and Portillo M.P. Effects of fluoxetine administration on neuropeptide Y and orexins in obese Zucker rat hypothalamus. Obesity Res. 10 (2002) 532-540
47. Hajos M., Richards C.D., Szekely A.D., and Sharp T. An electrophysiological and neuroanatomical study of the medial prefrontal cortical projection to the midbrain raphe nuclei in the rat. Neuroscience 87 (1998) 95-108
48. Hajos M., Hajos-Korcsok E., and Sharp T. Role of the medial prefrontal cortex in 5-HT1A receptor-induced inhibition of 5-HT neuronal activity in the rat. Br. J. Pharmacol. 126 (1999) 1741-1750
49. Harris H.J., Kotelevtsev Y., Mullins J.J., Seckl J.R., and Holmes M.C. Intracellular regeneration of glucocorticoids by 11beta-hydroxysteroid dehydrogenase-1 plays a key role in regulation of the hypothalamic-pituitary-adrenal axis: analysis of 11beta-HSD-1-deficient mice. Endocrinol. 142 (2001) 114-120
50. Havel P.J., Busch B.L., Curry D.L., Johnson D.R., and Dallman M.F. Predominately glucocorticoid agonist actions of RU-486 in young specific-pathogen-free Zucker rats. Am. J. Physiol. 271 (1996) R710-R717
51. Herkenham M., Lynn A.B., Little M.D., Johnson M., Melvin L.S., de Costa B.R., and Rice K.C. Cannabinoid receptor localization in brain. Proc. Natl. Acad. Sci. U.S.A. 87 (1990) 1932-1936
52. Herkenham M., Lynn A.B., Johnson M.R., Melvin L.S., de Costa B.R., and Rice K.C. Characterization and localization of cannabinoid receptors in rat brain: a quantitative in vitro autoradiographic study. J. Neurosci. 11 (1991) 563-583
53. Hill M.N., Ho W.S.V., Meier S.E., Gorzalka B.B., and Hillard C.J. Chronic corticosterone treatment increases the endocannabinoid 2-arachidonylglycerol in the rat amygdale. Eur. J. Pharmacol. 528 (2005) 99-102
54. Hill E.L., Gallopin T., Ferezou I., Cauli B., Rossier J., Schweitzer P., and Lambolez B. Functional CB1 receptors are broadly expressed in neocortical GABAergic and glutamatergic neurons. J. Neurophysiol. 97 (2007) 2580-2589
55. Hsieh C., Brown S., Derleth C., and Mackie K. Internalization and recycling of the CB1 cannabinoid receptor. J. Neurochem. 73 (1999) 493-501
56. Hurley K.M., Herbert H., Moga M.M., and Saper C.B. Efferent projections of the infralimbic cortex of the rat. J. Comp. Neurol. 308 (1991) 249-276
57. Inder W.J., Prickett T.C., Mulder R.T., Donlad R.A., and Joyce P.R. Reduction in basal afternoon plasma ACTH during early treatment of depression with fluoxetine. Psychopharmacol. (Berl) 156 (2001) 73-78
58. Jackson A.L., and Murphy L.L. Role of the hypothalamic-pituitary-adrenal axis in the suppression of luteinising hormone release by delta-9-tetrahydrocannabinol. Neuroendocrinol. 65 (1997) 446-452
59. Jamshidi N., and Taylor D.A. Anandamide administration into the ventromedial hypothalamus stimulates appetite in rats. Br. J. Pharmacol. 134 (2001) 1151-1154
60. Jankowsky M.P., and Sesack S.R. Prefrontal cortical projections to the rat dorsal raphe nucleus: ultrastructural features and associations with serotonin and gamma-aminobutyric acid neurons. J. Comp. Neurol. 468 (2004) 518-529
61. Jensen J.B., Jessop D.S., Harbuz M.S., Mork A., Sanchez C., and Mikkelsen J.D. Acute and long-term treatments with the selective serotonin reuptake inhibitor citalopram modulate the HPA axis activity at different levels in male rats. J. Neuroendocrinol. 11 (1999) 465-471
62. Jeong K.H., Sakihara S., Widmaier E.P., and Majzoub J.A. Impaired leptin expression and abnormal response to fasting in corticotrophin-releasing hormone-deficient mice. Endocrinol. 145 (2004) 3174-3181
63. Juckel G., Mendlin A., and Jacobs B.L. Electrical stimulation of rat medial prefrontal cortex enhances forebrain serotonin output: implications for electroconvulsive therapy and transcraneal magnetic stimulation in depression. Neuropsychopharmacol. 21 (1999) 391-398
64. Katona I., Sperlagh B., Sik A., Kafalvi A., Vizi E.S., Mackie K., and Freund T.F. Presynaptically located CB1 cannabinoid receptors regulate GABA release from axon terminals of specific hippocampal interneurons. J. Neurosci. 19 (1999) 4544-4558
65. Katona I., Urban G.M., Wallace M., Ledent C., Jung K.M., Piomelli D., Mackie K., and Freund T.F. Molecular composition of the endocannabinoid system at glutamatergic synapses. J. Neurosci. 26 (2006) 5628-5637 (2006)
66. Kirkham T.C., and Williams C.M. Synergistic effects of opioid and cannabinoid antagonists on food intake. Psychopharmacol. 153 (2001) 267-270
67. Kolb B. Prefrontal lesions alter eating and hoarding behavior in rats. Physiol. Behav. 12 (1974) 507-511
68. Kolb B. Functions of the frontal cortex of the rat: a comparative review. Brain Res. Rev. 8 (1984) 65-98
69. Kolb B., and Nonneman A.J. Prefrontal cortex and the regulation of food intake in the rat. J. Comp. Physiol. Psychol. 88 (1975) 806-815
70. Kosofsky B.E., and Molliver M.E. The serotoninergic innervation of cerebral cortex: different classes of axon terminals arise from dorsal and median raphe nuclei. Synapse 1 (1987) 153-168
71. Langley S.C., and York D.A. Increased type II glucocorticoid-receptor numbers and glucocorticoid-sensitive enzyme activities in the brain of the obese Zucker rat. Brain Res. 533 (1990) 268-274
72. Langley S.C., and York D.A. Effects of antiglucocorticoid RU 486 on development of obesity in obese fa/fa Zucker rats. Am. J. Physiol. 259 (1990) R539-R544
73. Langley S.C., and York D.A. Glucocorticoid receptor numbers in the brain and liver of the obese Zucker rat. Int. J. Obes. 16 (1992) 135-143
74. López de Jesús M., Sallés J., Meana J.J., and Callado L.F. Characterization of CB1 cannabinoid receptor immunoreactivity in postmortem human brain homogenates. Neuroscience 140 (2006) 635-643
75. Mailleux P., and Vanderhaeghen J.J. Distribution of neuronal cannabinoid receptor in the adult rat brain : a comparative receptor binding radioautography and in situ hybridization histochemistry. Neuroscience 48 (1992) 655-668
76. Mailleux P., and Vanderhaeghen J.J. Glucocorticoid regulation of cannabinoid receptor messenger RNA levels in the rat caudate-putamen. An in situ hybridization study. Neurosci. Lett. 156 (1993) 51-53
77. Malcher-Lopes R., Di S., Marcheselli V.S., Weng F.J., Stuart C.T., Bazan N.G., and Tasker J.G. Opposing crosstalk between leptin and glucocorticoids rapidly modulates synaptic excitation via endocannabinoid release. J. Neurosci. 26 (2006) 6643-6650
78. Mann C.D., Bich V.T., and Hrdina P.D. Protein kinase C in rat brain cortex and hippocampus: effect of repeated administration of fluoxetine and desipramine. Br. J. Pharmacol. 115 (1995) 595-600
79. Manns I.D., Sakmann B., and Brecht M. Sub- and suprathreshold receptive field properties of pyramidal neurons in layers 5A and 5B of rat somatosensory barrel cortex. J. Physiol. (Lond) 556 (2004) 601-622
80. Marsicano G., and Lutz B. Expression of the cannabinoid receptor CB1 in distinct neuronal subpopulations in the adult mouse forebrain. Eur. J. Neurosci. 11 (1999) 4213-4225
81. Mattsson C., Lai M., Noble J., McKinney E., Yau J.L., Seckl J.R., and Walker B.R. Obese Zucker rats have reduced mineralocorticoid receptor and 11beta-hydroxysteroid dehydrogenase Type 1 expression in hippocampus-implications for dysregulation of the hypothalamic-pituitary-adrenal axis in obesity. Endocrinol. 144 (2003) 2997-3003
82. Matsuda L.A., Lolait S.J., Brownstein M.J., Young A.L., and Bonner T.I. Structure of a cannabinoid receptor and functional expression of the cloned cDNA. Nature 346 (1990) 561-564
83. Matsuda L.A., Bonner T.I., and Lolait S.J. Localization of cannabinoid receptor mRNA in rat brain. J. Comp. Neurol. 327 (1993) 535-550
84. Moranta D., Esteban E., and García-Sevilla J.A. Differential effects of acute cannabinoid drug treatment, mediated by CB1 receptors, on the in vivo activity of tyrosine and tryptophan hydroxylase in the rat brain. Naunyn Schmiedeberg's Arch. Pharmacol. 369 (2004) 516-524
85. Moreira F.A., Kaiser N., Monory K., and Lutz B. Reduced anxiety-like behaviour induced by genetic and pharmacological inhibition of the endocannabinoid-degrading enzyme fatty acid amide hydrolase (FAAH) is mediated by CB1 receptors. Neuropharmacol. 54 (2008) 141-150
86. Murphy L.L., Muñoz R.M., Adrian B.A., and Villanua M.A. Function of cannabinoid receptors in the neuroendocrine regulation of hormone secretion. Neurobiol. Dis. 5 (1998) 432-446
87. Need A.B., Davis R.J., Alexander-Chacko J.T., Eastwood B., Chernet E., Phebus L.A., Sindelar D., and Nomikos G.G. The relationship of in vivo central CB1 receptor occupancy to changes in cortical monoamine release and feeding elicited by CB1 receptor antagonists in rats. Psychopharmacol. (Berl) 184 (2006) 26-35
88. Ohliger-Frerking P., Horwitz B.A., and Horowitz J.M. Serotonergic dorsal raphe neurons from obese Zucker rats are hyperexcitable. Neuroscience 120 (2003) 627-634
89. Oliva J.M., Urigüen L., Pérez-Rial S., and Manzanares J. Time course of opioid and cannabinoid gene transcription alterations induced by repeated administration with fluoxetine in the rat brain. Neuropharmacol. 49 (2005) 618-626
90. Orosco M., Trouvin J.H., Cohen Y., and Jacquot C. Ontogeny of brain monoamines in lean and obese female Zucker rats. Physiol. Behav. 36 (1986) 853-856
91. Pesonen U., Koulu M., Heikinheimo O., and Huupponen R. The glucocorticoid antagonist mifepristone reveals abnormal regulation of the adrenocortical system in obese Zucker rats. J. Endocrinol. 132 (1992) 425-431
92. Pesonen U., Jolkkonen J., Huupponen R., and Koulu M. Differential hypothalamic arginine vasopressin response to glucocorticoid receptor antagonism in lean and obese Zucker rats. Neuroendocrinol. 56 (1992) 271-277
93. Petrovich G.D., Holland P.C., and Gallagher M. Amygdalar and prefrontal pathways to the lateral hypothalamus are activated by a learned cue that stimulates eating. J. Neurosci. 25 (2005) 8295-8302
94. Pettit D.A.D., Harrison M.P., Olson J.M., Spencer R.F., and Cabral G.A. Immunohistochemical localization of the neural cannabinoid receptor in rat brain. J. Neurosci. Res. 51 (1998) 391-402
95. A responses in hippocampal pyramidal cells. J. Neurosci. 12 (1992) 4122-4132
96. Price G., Giovannoni G., and Baker D. Mifepristone or inhibition of 11beta-hydroxylase activity potentiates the sedating effects of the cannabinoid receptor-1 agonist delta(9)-tetrahydrocannabinol in mice. Neurosci. Lett. 341 (2003) 164-166
97. Puder M., Weidenfeld J., Chowers I., Nir I., Conforti N., and Siegel R.A. Corticotropin and corticosterone secretion following delta-1-tetrahydrocannabinol in intact and in hypothalamic deafferentated male rats. Exp. Brain Res. 46 (1982) 85-88
98. Puig M.V., Celada P., Díaz-Mataix L., and Artigas F. In vivo modulation of the activity of pyramidal neurons in the rat medial prefrontal cortex by 5-HT2A receptors. Relationship to thalamocortical afferents. Cereb. Cortex 13 (2003) 1870-1882
99. Risold P.Y., Thompson R.H., and Swanson L.W. The structural organization of connections between hypothalamus and cerebral cortex. Brain Res. Rev. 24 (1997) 197-254
100. Roe A.L., Howard G., and Blouin R.A. Characterization of nuclear protein binding (AP-1, GR, and STAT) in the genetically obese (fa/fa) Zucker rat. Life Sci. 63 (1998) 1339-1346
101. Routh V.H., Stern J.S., and Horwitz B.A. Serotonergic activity is depressed in the ventromedial hypothalamic nucleus of 12-day-old obese Zucker rats. Am. J. Physiol. 267 (1994) R712-R719
102. Sagredo O., Ramos J.A., Fernandez-Ruiz J., Rodriguez M., and de-Miguel R. Chronic delta-9-tetrahydrocannabinol administration affects serotonin levels in the rat frontal cortex. Naunyn-Schmiedebergs Arch. Pharmacol. 372 (2006) 313-317
103. Sallés J., Wallace M.A., and Fain J.N. Differential effects of alkylating agents on the multiple muscarinic receptor subtypes linked to the activation of phospholipase C by carbachol in rat brain cortical membranes. J. Pharmacol. Exp. Ther. 264 (1993) 521-529
104. Seckl J.R., and Fink G. Antidepressants increase glucocorticoid and mineralocorticoid receptor mRNA expression in rat hippocampus in vivo. Neuroendocrinol. 55 (1992) 621-626
105. Semont A., Fache M.P., Hery F., Faudon M., Youssouf F., and Hery M. Regulation of central corticosteroid receptors following short-term activation of serotonin transmission by 5-hydroxy-tryptophan or fluoxetine. J. Neuroendocrinol. 12 (2000) 736-744
106. Sesack S.R., Deutch A.Y., Roth R.H., and Bunney B.S. Topographical organization of the efferent projections of the medial prefrontal cortex in the rat: an anterograde tract-tracing study with Phaseoulus vulgaris leucoagglutinin. J. Comp. Neurol. 290 (1989) 213-242
107. Shire D., Carillon C., Kaghad M., Calandra B., Rinaldi-Carmona M., Le Fur G., Caput D., and Ferrara P. An amino-terminal variant of the central cannabinoid receptor resulting from alternative splicing. J. Biol. Chem. 270 (1995) 3726-3731
108. Svec F., Thompson H., Corll C., and Porter J. Levels of hypothalamic neurotransmitters in lean and obese Zucker rats. Nutritional Neurosci. 5 (2002) 321-326
109. Tanda G., Carboni E., Frau R., and Di Chiara G. Increase of extracellular dopamine in the prefrontal cortex: a trait of drugs with antidepressant potential?. Psychopharmacol. (Berl) 115 (1994) 285-288
110. Tataranni P., Gautier J.F., Chen K., Vecker A., Bandy D., Salbe A., Pratley R., Lawson M., Reiman E., and Ravussen E. Neuroanatomical correlates of hunger and satiation in humans using positron emission tomography. Proc. Natl. Acad. Sci. U.S.A. 96 (1999) 4569-4574
111. Thrybom T., Rooth P., and Lindström P. Effect of serotonin reuptake inhibitor on syndrome development in obese hyperglycaemic mice (ob/ob). Metabolism 50 (2001) 144-150
112. Timofeeva E., and Richard D. Functional activation of CRH neurons and expression of the genes encoding CRH and its receptors in food-deprived lean (Fa/?) and obese (fa/fa) Zucker rats. Neuroendocrinol. 66 (1997) 327-340
113. Timofeeva E., and Richard D. Activation of the central nervous system in obese Zucker rats during food deprivation. J. Comp. Neurol. 441 (2001) 71-89
114. Trettel J., and Levine E.S. Cannabinoids depress inhibitory synaptic inputs received by layer 2/3 pyramidal neurons of the neocortex. J. Neurophysiol. 88 (2002) 534-539
115. Trettel J., and Levine E.S. Endocannabinoids mediate rapid retrograde signaling at interneuron right-arrow pyramidal neuron synapses of the neocortex. J. Neurophysiol. 89 (2003) 2334-2338
116. Tsou K., Brown S., Sañudo-Peña M.C., Mackie K., and Walker J.M. Immunohistochemical distribution of cannabinoid CB1 receptors in the rat central nervous system. Neuroscience 83 (1998) 393-411
117. Tzavara E.T., Davis R.J., Perry K.W., Li X., Salhoff C., Bymaster F.P., and Witkin J.M. The CB1 receptor antagonist SR141716A selectively increases monoaminergic neurotransmission in the medial prefrontal cortex: implications for therapeutic actions. Br. J. Pharmacol. 138 (2003) 544-553
118. White B.D., and Martin R.J. Alterations in the binding characteristics of glucocorticoid receptors from obese Zucker rat. J. Steroid Biochem. 36 (1990) 681-686
119. Wieczorek I., Schultz C., Jarry H., and Lehnert H. The effects of the selective serotonin reuptake inhibitor fluvoxamine on body weight in Zucker rats are mediated by corticotrophin-releasing hormone. Int. J. Obes. 25 (2001) 1566-1569
120. Wilson R.I., and Nicoll R.A. Endocannabinoid signalling in the brain. Science 296 (2002) 678-682
121. Wise S.P., and Jones E.G. Cells of origin and terminal distribution of descending projections of the rat somatic sensory cortex. J. Comp. Neurol. 175 (1977) 129-157
122. Yau J.L., Noble J., Kenyon C.J., Hibberd C., Kotelevstsev Y., Mullins J.J., and Seckl J.R. Lack of tissue glucocorticoid reactivation in 11beta-hydroxysteroid dehydrogenase type 1 knockout mice ameliorates age-related learning impairments. Proc. Natl. Acad. Sci. U.S.A. 98 (2001) 4716-4721
123. Zilles K., and Wree A. Cortex: areal and laminar structure. In: Paxinos G. (Ed). The rat nervous system (1995), Academic Press, New York 649-685